UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System

PALO ALTO, Calif., Oct. 17, 2017 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Le... Devices, Oncology Varian Medical Systems, Halcyon, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news